This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gong, G. Articles by Waldman, F. M. Search for Related Content PubMed PubMed Citation Articles by Gong, G. Articles by Waldman, F. M.

Genetic Changes in Paired Atypical and Usual Ductal Hyperplasia of the Breast by Comparative Genomic Hybridization¹

Cancer Center [S. D., K. C., F. M. W.] and Departments of Pathology [I. C., B-M. L.] and Laboratory Medicine [F. M. W.], University of California San Francisco, San Francisco, California 94143-0808, and Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 138-736 [G. G.]

Purpose: Breast cancer is thought to develop from noninvasive precursor lesions, although the earliest steps of neoplastic transformation are still undefined. Usual ductal hyperplasia (UDH) is considered to represent a benign proliferation of ductal epithelial cells, whereas atypical ductal hyperplasia (ADH) may represent the first clonal neoplastic expansion of these cells. The aim of this study was to examine genetic alterations in UDH and ADH and to determine the relationship between these lesions in the same breast biopsy.

Experimental Design: Comparative genomic hybridization analysis was used to define copy number alterations in DNA extracted from archival sections of 18 patients. Nine patients showed ADH with adjacent UDH, and nine showed pure UDH. None showed evidence of invasive cancer or ductal carcinoma in situ.

Results: Five of the nine ADH lesions showed chromosome copy number alterations. 16q loss (five cases) and 17p loss (two cases) were the most frequent changes. The associated UDH lesions in these five patients also showed copy number alterations, always a subset of the changes present in the paired ADH. In one other patient, the UDH showed eight chromosomal alterations, whereas the paired ADH showed no changes. Only one of nine cases with pure UDH showed comparative genomic hybridization abnormalities.

Conclusions: These data support the likelihood that UDH is a precursor of ADH, at least in some cases representing neoplastic growth. The frequencies of 16q and 17p losses suggest that alterations of candidate genes located in these chromosomal regions may play a role early in breast carcinogenesis.

This article has been cited by other articles:

				E. Kapenhas-Valdes, S. M. Feldman, and S. K. Boolbol The Role of Mammary Ductoscopy in Breast Cancer: a Review of the Literature Ann. Surg. Oncol., December 1, 2008; 15(12): 3350 - 3360. [Abstract] [Full Text] [PDF]

				P. M. Neilsen, K. M. Cheney, C.-W. Li, J. D. Chen, J. E. Cawrse, R. B. Schulz, J. A. Powell, R. Kumar, and D. F. Callen Identification of ANKRD11 as a p53 coactivator J. Cell Sci., November 1, 2008; 121(21): 3541 - 3552. [Abstract] [Full Text] [PDF]

				A. Rizki, V. M. Weaver, S.-Y. Lee, G. I. Rozenberg, K. Chin, C. A. Myers, J. L. Bascom, J. D. Mott, J. R. Semeiks, L. R. Grate, et al. A Human Breast Cell Model of Preinvasive to Invasive Transition Cancer Res., March 1, 2008; 68(5): 1378 - 1387. [Abstract] [Full Text] [PDF]

				C J Fabian, B F Kimler, M S Mayo, and S A Khan Breast-tissue sampling for risk assessment and prevention Endocr. Relat. Cancer, June 1, 2005; 12(2): 185 - 213. [Abstract] [Full Text] [PDF]

				S. DeVries, S. Nyante, J. Korkola, R. Segraves, K. Nakao, D. Moore, H. Bae, M. Wilhelm, S. Hwang, and F. Waldman Array-Based Comparative Genomic Hybridization from Formalin-Fixed, Paraffin-Embedded Breast Tumors J. Mol. Diagn., February 1, 2005; 7(1): 65 - 71. [Abstract] [Full Text] [PDF]

				E. S. Hwang, S. DeVries, K. L. Chew, D. H. Moore II, K. Kerlikowske, A. Thor, B.-M. Ljung, and F. M. Waldman Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In situ Clin. Cancer Res., August 1, 2004; 10(15): 5160 - 5167. [Abstract] [Full Text] [PDF]

				E. Tan-Chiu, J. Wang, J. P. Costantino, S. Paik, C. Butch, D. L. Wickerham, B. Fisher, and N. Wolmark Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer J Natl Cancer Inst, February 19, 2003; 95(4): 302 - 307. [Abstract] [Full Text] [PDF]

				M. Kochetkova, O. L. D. McKenzie, A. J. Bais, J. M. Martin, G. A. Secker, R. Seshadri, J. A. Powell, S. J. Hinze, A. E. Gardner, H. E. Spendlove, et al. CBFA2T3 (MTG16) Is a Putative Breast Tumor Suppressor Gene from the Breast Cancer Loss of Heterozygosity Region at 16q24.3 Cancer Res., August 15, 2002; 62(16): 4599 - 4604. [Abstract] [Full Text] [PDF]